A. van Dalen
- Oncology top 5%
- Molecular Biology
- Pathology and Forensic Medicine top 5%
- Surgery
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- C. SturgeonR. LamerzR KlapdorMichael J. DuffyCaj HaglundOndřej TopolčanLars‐Erik HanssonPaïvi Peltomäki
- Topics
- HER2/EGFR in Cancer Research (6 papers)Ovarian cancer diagnosis and treatment (6 papers)Glycosylation and Glycoproteins Research (4 papers)
- Journals
- Journal of Molecular BiologyJournal of Colloid and Interface ScienceEuropean Journal of Cancer
- Partner nations
- NetherlandsUnited KingdomGermany
In The Last Decade
A. van Dalen
49 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 114
- Oncology 589
- Molecular Biology 514
- Pathology and Forensic Medicine 295
- Surgery 233
- Pulmonary and Respiratory Medicine 230
Countries citing papers authored by A. van Dalen
This map shows the geographic impact of A. van Dalen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. van Dalen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. van Dalen more than expected).
Fields of papers citing papers by A. van Dalen
This network shows the impact of papers produced by A. van Dalen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. van Dalen. The network helps show where A. van Dalen may publish in the future.
Co-authorship network of co-authors of A. van Dalen
This figure shows the co-authorship network connecting the top 25 collaborators of A. van Dalen. A scholar is included among the top collaborators of A. van Dalen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. van Dalen. A. van Dalen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 393 | |
| 2 | Vascular endothelial growth factor (VEGF) concentration in sera and tumor effusions from patients with ovarian carcinoma. | 35 |
| 3 | 300 | |
| 4 | 9 | |
| 5 | 10 | |
| 6 | 10 | |
| 7 | 45 | |
| 8 | 2 | |
| 9 | Multicentre tumour marker reference range study. | 19 |
| 10 | 1 | |
| 11 | 3 | |
| 12 | 19 | |
| 13 | 23 | |
| 14 | 139 | |
| 15 | Monoclonal antibody M3 used in TPS assay for the quantification of TPA recognizes keratin 18 | 0 |
| 16 | 39 | |
| 17 | 33 | |
| 18 | 10 | |
| 19 | 1 | |
| 20 | Inclusion of Some Organic Acid in Micelle of Dinonylnaphthalene Sulfonic Acid | 2 |
About A. van Dalen
A. van Dalen is a scholar working on Reproductive Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 50 papers that have together received 1.4k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (6 papers), Ovarian cancer diagnosis and treatment (6 papers) and Glycosylation and Glycoproteins Research (4 papers). The work is most often cited by research in Oncology (589 citations), Pathology and Forensic Medicine (295 citations) and Cancer Research (214 citations). A. van Dalen has collaborated with scholars based in Netherlands, United Kingdom and Germany. Frequent co-authors include C. Sturgeon, R. Lamerz, R Klapdor, Michael J. Duffy, Caj Haglund, Ondřej Topolčan, Lars‐Erik Hansson, Païvi Peltomäki, Elke Holinski‐Feder and Durk Fekkes. Their work appears in journals such as Journal of Molecular Biology, Journal of Colloid and Interface Science and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.